Matinas BioPharma
rapid evolution of platforms sets stage for further development | Matinas BioPharma
Company
Deck Type
Sector
Industry
Deck date
August 2023
Slide
25 of 28
Similar slides by Matinas BioPharma
See diffirences between slides (animation)
Investor Presentation
May 2023
rapid evolution of platforms sets stage for further development | Matinas BioPharma
Related slides by other companies
AbCellera
Investor Conference
January 2024
continued focus on high value programs and strategic partnerships with our differentiated technology position in liquidity we have a long cash runway for focused investment execution completion of engine over the next years we will continue to invest in the final stage of our engine including construction commissioning of our manufacturing facility our portfolio of partnered in we anticipate partnership deals from our cell engager platform our partnership strategy is to select high value not deal volume our portfolio of internal we expect to enter clinical development in in we expect additional first in class development candidates from our ion channel platform | AbCellera
Absci
Investor Presentation
October 2023
integrated drug creation platform | Absci
Chimerix
Mergers and Acquisitions
January 2021
deep pipeline across all development stages | Chimerix
AstraZeneca
Investor Presentation
March 2022
| AstraZeneca
Other recent decks by Matinas BioPharma
See all presentations (7 decks)
Investor Presentation
March 2024
Investor Presentation
February 2024
Investor Presentation
January 2024
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io